Delivery Order SPE2DB20D7059-SPE2DB25FQNU9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Nalbuphine 100 mg/10 mL vials with a firm fixed price ceiling value of $1,270.82. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 23, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nalbuphine 100 mg/10 mL vials with a ceiling value of $1,366.25. This firm fixed-price, non-set-aside contract is classified as a delivery order and is scheduled for completion by September 9, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,230.32 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 ml vials on January 20, 2026, with completion scheduled for January 21, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,845.48 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 ml vials on December 2, 2025, with an ultimate completion date of December 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nalbuphine 10ML in quantities of 25 units, with a ceiling value of $2,460.64. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by November 20, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- <p>The Defense Logistics Agency issued a $1,230.32 delivery order to AmerisourceBergen Drug Corp on February 26, 2026, for nalbuphine 100 mg/10 ml vials.</p> <p>The order was issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026. Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of February 27, 2026.</p>
- The Defense Logistics Agency awarded a delivery order valued at $1,688.22 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 22, 2026. The product will be performed from the awardee's location in Conshohocken, Pennsylvania. Nalbuphine is a synthetic opioid analgesic used in pain management and anesthesia support, making this delivery order consistent with the Defense...
- The Defense Logistics Agency awarded a $5,569.18 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Nalbuphine 200 mg/10 mL vials. This competitive, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of October 31, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Nalbuphine is an opioid analgesic commonly used in military and federal healthcare settings for pain...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for nalbuphine 100 mg/10 ml vial (10 ml), with a ceiling value of $1,230.32 under firm fixed pricing. Place of performance is Conshohocken, PA. The order completion date is March 3, 2026. No set-aside was used in this award. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and holds a $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical running through...
- The Defense Logistics Agency awarded a $6,055.30 delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Nalbuphine 100 mg/10 mL vials. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by January 22, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Nalbuphine is an opioid analgesic commonly used within military and federal healthcare systems for pain management...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQNU9Delivery Order
The Defense Logistics Agency awarded a $1,270.82 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Nalbuphine 100 mg/10 ml vials. This is a firm fixed price, non-set-aside delivery order with a completion date of August 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The larger IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/21/25 |